Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2026-02-17 @ 8:38 PM
Study NCT ID:
NCT03920657
Status:
TERMINATED
Last Update Posted:
2022-11-21
First Post:
2018-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Early and Low Dose Deferasirox (3.5 mg/kg FCT) to Suppress NTBI and LPI as Early Intervention to Prevent Tissue Iron Overload in Lower Risk MDS
Sponsor:
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FISM_IRON-MDS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None